Home / Press Release  / ZEISS India signs a multi-year strategic partnership with Dr. Agarwal’s EyeHospital and Narayana Nethralaya

ZEISS India signs a multi-year strategic partnership with Dr. Agarwal’s EyeHospital and Narayana Nethralaya

Collaboration with two of India’s leading eye-care institutions to  accelerate and expand access to advanced eye care through ZEISS technologies across cataract, refractive and laser vision correction The MoU was signed at ESCRS 2026 (London)  The collaboration

ZEISS India Partnership
  • Collaboration with two of India’s leading eye-care institutions to  accelerate and expand access to advanced eye care through ZEISS technologies across cataract, refractive and laser vision correction
  • The MoU was signed at ESCRS 2026 (London) 
  • The collaboration also establishes pathways for participation in clinical studies, scientific evaluations and evidence-generation initiatives

Memorandum of Understanding (MoU) with Dr. Agarwal’s Eye Hospital and Narayana Nethralaya during the 44th Congress of the ESCRS Annual Congress hosted at the ExCeL exhibition centre in London. This milestone reflects a longstanding relationship between the Parties that provides an opportunity to further strengthen clinical collaboration and technology adoption in both cataract and refractive surgeries.

The collaboration will focus on advancing clinical excellence and expand the adoption of ZEISS intraocular lens technologies, while continuing joint work through ZEISS VISUMAX 800 and SMILE pro® platforms for refractive surgery. It will also include educational programmes, training and knowledge exchange in cataract and refractive surgery. The partnership will promote best practices in IOL selection, cataract procedures and laser vision correction. It will further support participation in clinical studies, scientific evaluations and evidence-generation initiatives, along with the sharing of clinical experience and research findings at national and international ophthalmology conferences.

Dipu Bose, Head – Medical Technology, ZEISS India and Neighbouring Markets, said, “As a foundation-owned company, we take a thoughtful approach to partnership led by shared values, trust and sustainable impact. Our collaboration with Dr Agarwal’s Eye Hospital and Narayana Nethralaya reflects our common commitment to patient-centred eye care and clinical excellence. Their extensive network and reach will help us make our advanced technologies accessible to more patients, while providing valuable insights into evolving clinical practices and patient needs. Through this MoU, we look forward to deepening our collaboration and contributing to the continued advancement of eyecare segment in India.”

Dr. Ashvin Agarwal, Chief Clinical Officer, Dr. Agarwal’s Eye Hospital, said, “Our partnership with ZEISS brings together advanced technology and clinical expertise to address the changing needs of patients. By strengthening access to innovative cataract and refractive solutions, we aim to make eye care more precise, personalized and accessible, while continuing to uphold the highest standards of patient care.”

Dr. Naren Shetty, Vice Chairman and Head of Cataract and Refractive Lens Services, Narayana Nethralaya, said, “Our association with ZEISS is an opportunity to contribute to the future of ophthalmology through evidence-based practice, professional education and collaborative research. By combining our clinical experience with ZEISS’s technological capabilities, we seek to advance standards of care, strengthen clinical outcomes and support the wider adoption of high-quality ophthalmic solutions across India.”

Together through this collaboration, ZEISS and the Partners will continue to support innovation, knowledge exchange and improved patient outcomes.

medgatetoday@gmail.com

Review overview
NO COMMENTS

POST A COMMENT

This site uses Akismet to reduce spam. Learn how your comment data is processed.

 

 
MedgateToday

Every major healthcare update,
delivered to your inbox

Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.

 

🔒 No spam. Unsubscribe anytime.